IGNIFI ANNOUNCES NEW LEADERSHIP TEAM FOR NEXT PHASE OF GROWTH
January 9, 2023 |
Creative healthcare marketing agency IGNIFI has announced its new senior leadership team, which includes the appointment of a new Managing Director for 2023 to lead the business into its next phase of growth and development.
(From left) IGNIFI Digital Director Craig Lambert, new Managing Director John Horn, former Managing Director Dave Watson, Strategic Healthcare Director Joe McCarthy, Finance Director Ruth Green and Group Account Director Sarah Thompson.
Photo credit: Martin Avery Photography
Creative healthcare marketing agency IGNIFI has announced its new senior leadership team, which includes the appointment of a new Managing Director for 2023 to lead the business into its next phase of growth and development.
IGNIFI was acquired by marketing agency group, Selbey Anderson, two years ago, and as part of a planned succession, long-standing Managing Director, Dave Watson, will now hand over to John Horn.
As the company’s former Operations Director, John has been a fundamental part of IGNIFI’s ongoing success and growth for more than 20 years. He will be supported in his new role by an expert leadership team, which includes Group Account Director, Sarah Thompson; Strategic Healthcare Director, Joe McCarthy; Digital Director, Craig Lambert; and Finance Director, Ruth Green.
“I am delighted that this special agency, which myself and others have dedicated many years to building, is in safe and capable hands, ready for further growth in 2023 and beyond,” commented Dave Watson. “It’s been a privilege to work alongside colleagues and clients that make a real difference to the lives of people and animals. I wish John and the IGNIFI team all the best with supporting our healthcare clients to achieve even more success together in the future.”
Since 2020, IGNIFI has benefited from an increase in demand from its healthcare clients for creative and marketing campaigns in digital formats. Healthcare and pharmaceutical brands have seen a rapid digital transformation across the industry and the need for agencies, like IGNIFI, to support them to stay at the forefront of creative and digital communications has never been greater. Over the course of 2022, IGNIFI has expanded its client portfolio and continued to expand its team of talented experts, increasing the agency headcount to 30 members of staff to support client needs and future growth.
John Horn, IGNIFI’s new Managing Director commented:
“I am very excited by this opportunity to lead our new senior leadership team and I look forward to utilising our many decades of healthcare agency and industry experience to further support clients with their marketing communication needs. We enter 2023 with a collective drive to build on the solid foundations that already exist and with a shared determination to continue to deliver IGNIFI’s exceptional service.”
IGNIFI is a North East based creative and digital marketing agency working exclusively in human and animal health, pharmaceuticals and biotech for global brands.
0191 423 8000
This content was provided by IGNIFI
Company Details
Latest Content from IGNIFI
HOW TO TRANSFORM YOUR HEALTHCARE BRAND MARKETING FROM MULTI-CHANNEL TO OMNICHANNEL
In a previous blog, we outlined the role of omnichannel in healthcare and the importance of personalised communications with the suggestion of using modular content to support an omnichannel approach. No...
Going beyond the buzzword: omnichannel and healthcare marketing
The concept of omnichannel often gets confused with multichannel, with many pharma companies believing they are operating omnichannel when in fact it is a multichannel approach. In our latest blog,...
The ever-shifting landscape of health wearables
Back in 2018, we published a whitepaper discussing the growing trend of wearables in healthcare, along with the impact that this could potentially have on both patients and the healthcare...
IGNIFI ANNOUNCES NEW LEADERSHIP TEAM FOR NEXT PHASE OF GROWTH
Creative healthcare marketing agency IGNIFI has announced its new senior leadership team, which includes the appointment of a new Managing Director for 2023 to lead the business into its next...
Diabetes management – should there be a 'one-size fit all' approach?
For Diabetes Awareness Week 2022, we discussed diabetes as a chronic condition, and the increasing importance of home-based disease management.
How whole genome sequencing is revolutionising the rare disease patient experience
In this white paper, we discuss how whole genome sequencing (WGS) projects and the data sets they produce are paving the way for developments in research, diagnosis, and early interventions...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
How marketers are balancing the changing trends in women's health
We’ve reached a turning point in the way we view and provide healthcare to women. In the midst of discontent with the way that women are treated in healthcare and...
Improving healthcare for rare disease patients
Following on from Rare Disease Day 2022, we decided to take a deeper look into the patient journey of those living with a rare health condition. In this blog, we...
Could femtech be the answer to the gender health gap?
Here, we discuss the phenomenon of femtech, an industry that puts women’s experiences of lifestyle and health front and centre. We highlight some of the major players in the industry,...